Dear Supporters and Friends,
We've got some good and tough news to share. Thanks to your incredible support in 2022, Kevin fought hard against his illness and had moments where it seemed like he was winning.
But here's the tough part: the treatment that was working has stopped doing its job. Kevin's oncologist tried to get him into a clinical trial for a new treatment, but sadly Kevin wasn’t accepted. Now, his last hope is an IV Avastin (Bevacizumab) combined with an oral drug called Lonsurf. These have had great results in others, but the monthly costs are high: $7018 plus scans and consults.
Kevin has taken the first step by investing $5018 into this treatment. He's planning to go through four rounds and see if it works. But we can't do this alone. We need your help once more, but without your support, the cost is out of reach. This is Kevin's final stand against a tough opponent. The doctors say he has four to five months without a breakthrough. We can't accept that without trying everything.
This latest option is Kevin's lifeline, but it's fully privately funded. Your contribution can make this possible.
Your kindness, compassion, and generosity have already meant the world to him, and now, once again, your support, big or small, can change everything. Let's come together, friends and supporters, to give Kevin the chance he deserves and keep him on stage for as long as possible.
Thank you from the bottom of our hearts,
Maria Low on behalf of the Greaves family